| Parameters | Description |
|---|---|
| Category of Drug 3 | Betaxolol is an Ophthalmological Preparations drug |
| Mechanism of Action | Betaxolol is a selective blocker of catecholamine stimulation of beta(1)-adrenergic receptors in the heart and vascular smooth muscle. |
| Indications | Betaxolol is used for Glaucoma |
| Chemical Structure 2 | |
| IUPAC name | 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-ol |
| Molecular details | Molecular Formula: C18H29NO3 Molecular Weight: 307.4 g/mol |
| Well Known Pharmaceutical Brands | IOBET- FDC |
| Available dosage forms | EYE DROPS![]() |
| Dose 1 | Instillation into the eye Adult- 1 to 2 drops, twice daily. Child- Not recommended. |
| Pharmacokinetic properties | 1. bioavailability of 89% ± 5% 2. Volume of distribution- Not Available 3. Protein binding- 50% 4. Metabolism- Primarily hepatic. 5. Half-life- 14-22 hours |
| Contraindications | 1. Systemic absorption may follow topical application to the eyes 2. Heart block, or uncontrolled heart failure 3. Hypersensitivity |
| Precautions | 1. Avoid in asthma 2. Poor cardiac reserve 3. Hepatic impairment 4. Not for injection 5. Pregnancy |
| Adverse Effects | 1. Ocular stinging 2. Burning 3. Pain 4. Itching 5. Erythema 6. Dry eyes 7. Allergic reactions |
| Pregnancy Category | C |
Other Ophthalmic preparation
- Acetazolamide
- Clonidine
- Latanoprost
- Physostigmine
- Pilocarpine
- Timolol



Pingback: Acetazolamide- Indications, Dosage, Contraindications, ADRs - PharmaCampus
Pingback: Acetazolamide- Ophthalmic preparation used in Glaucoma - PharmaCampus